600276 恒瑞医药
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额11,235,3787,422,7537,643,6651,265,2654,218,816
投资活动产生之现金流量净额(2,740,502)(1,911,986)1,222,315390,289(546,263)
筹资活动产生之现金流量净额7,781,707(1,550,590)(3,144,426)(318,770)(998,322)
汇率变动对现金及现金等价物的影响(360,133)7,40112,53380,497(16,866)
现金及现金等价物净增加/(减少)15,916,4513,967,5785,734,0871,417,2812,657,365
期初现金及现金等价物余额24,239,10220,271,52414,537,43713,120,15610,462,791
期末现金及现金等价物余额40,155,55324,239,10220,271,52414,537,43713,120,156